TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/29/05 12:01 | 12/28/05 | AGIX | Atherogenics Inc | GA | Health | Drug | Pharmaceutical Preparations | Alexander R Wayne | GA | D | S | -502 | 20.09 | 0 | -25 | -5 | 436 | D | |||||||||||||||
8/11/05 09:11 | 8/9/05 | AGIX | Atherogenics Inc | GA | Health | Drug | Pharmaceutical Preparations | Alexander R Wayne | GA | D | M.d | 3 | 0.1000 | 0 | 25 | 6 | 461 | D | |||||||||||||||
2/23/05 17:43 | 2/18/05 | AGIX | Atherogenics Inc | GA | Health | Drug | Pharmaceutical Preparations | Alexander R Wayne | GA | D | M.d | 8 | 0.1000 | 0 | 75 | 21 | 436 | D | |||||||||||||||
2/23/05 17:43 | 2/18/05 | AGIX | Atherogenics Inc | GA | Health | Drug | Pharmaceutical Preparations | Alexander R Wayne | GA | D | S.d | -1,324 | 17.65 | 0 | -75 | -15 | 436 | D | |||||||||||||||
2/18/04 19:13 | 2/13/04 | AGIX | Atherogenics Inc | GA | Health | Drug | Pharmaceutical Preparations | Alexander R Wayne | GA | D | S.m | -2,111 | 21.11 | 0 | -100 | -50 | 100 | I | |||||||||||||||
2/18/04 19:02 | 5/1/03 | AGIX | Atherogenics Inc | GA | Health | Drug | Pharmaceutical Preparations | Alexander R Wayne | GA | D | S.a | -594 | 9.14 | 0 | -65 | -11 | 536 | M |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |